Chronic kidney disease signs | 35–44 years | 45–54 years | 55–64 years | Total | ||||
---|---|---|---|---|---|---|---|---|
Male (n = 1,204) | Female (n = 630) | Male (n = 1,559) | Female (n = 1,232) | Male (n = 1,201) | Female (n = 836) | Male (n = 3,964) | Female (n = 2,698) | |
Proteinuria (dipstick measurement)a | ||||||||
 1+ | 1.7 | 0.8 | 1.6 | 1.2 | 2.3 | 0.7 | 1.9 | 1.0 |
 ≥2+ | 0.6 | 0.0 | 0.9 | 0.2 | 1.5 | 0.1 | 1.0 | 0.1 |
eGFR (mL/min/1.73Â m2)b | ||||||||
 G1: ≥90 | 8.2 | 13.8 | 3.4 | 5.5 | 3.6 | 2.4 | 4.9 | 6.5 |
 G2: 60–89 | 85.7 | 80.2 | 82.3 | 79.0 | 74.2 | 75.0 | 80.9 | 78.0 |
 G3a: 45–59 | 5.7 | 6.0 | 13.8 | 15.5 | 21.0 | 22.0 | 13.5 | 15.3 |
 G3b: 30–44 | 0.1 | 0.0 | 0.4 | 0.0 | 1.0 | 0.5 | 0.5 | 0.1 |
 G4: 15–29 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | <0.1 |
 G5: ≤14 | 0.2 | 0.0 | 0.1 | 0.0 | 0.2 | 0.0 | 0.2 | 0.0 |
CKD severity (mL/min/1.73Â m2)b | ||||||||
 Mild | 7.0 | 6.5 | 14.0 | 15.5 | 21.0 | 22.2 | 14.0 | 15.5 |
 Moderate | 0.6 | 0.2 | 1.3 | 0.6 | 2.3 | 0.6 | 1.4 | 0.5 |
 Severe | 0.3 | 0.0 | 0.5 | 0.1 | 1.0 | 0.2 | 0.6 | 0.1 |